Related Experiment Video
Updated: Jul 8, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
[Trimetazidine-induced encephalopathy with choreiform disorders: a case report]
J Sivet1, B de la Gastine, B Mosquet
1Centre régional de pharmacovigilance de Caen Basse-Normandie, CHRU Côte de Nacre, 14033 Caen cedex, France.
Trimetazidine can cause choreiform movement disorders, a condition not previously documented. This case report highlights the need to discontinue trimetazidine if motor symptoms like chorea appear.
Area of Science:
- Neurology
- Pharmacology
Background:
- Trimetazidine is a medication commonly used for angina pectoris.
- While known to cause parkinsonism, its association with choreiform disorders is not established.
Observation:
- An 88-year-old patient on trimetazidine developed choreiform movements, gait disturbances, tremor, and visual hallucinations.
- These neurological symptoms resolved completely after discontinuing trimetazidine.
Findings:
- This case suggests trimetazidine can induce choreiform disorders, similar to other drugs with a piperazinic ring like neuroleptics.
- The mechanism may involve anti-dopaminergic effects, although trimetazidine's primary action is metabolic.
Implications:
- Clinicians should consider trimetazidine as a potential cause of choreiform movement disorders.
- Prompt drug withdrawal is crucial for managing drug-induced movement abnormalities.
Related Concept Videos
Hepatic Encephalopathy
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Encephalitis l: Introduction
Alterations in Muscle Tone lll

